Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025
Carlsmed (Nasdaq: CARL), a medical technology company focused on AI-enabled personalized spine surgery solutions, has scheduled its second quarter 2025 financial results announcement for August 28, 2025, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Carlsmed (Nasdaq: CARL), a medical technology company focused on AI-enabled personalized spine surgery solutions, has scheduled its second quarter 2025 financial results announcement for August 28, 2025, after market close.
The company will host a conference call and webcast at 1:30 PM Pacific Time on the same day. Participants are advised to register 5-10 minutes before the call begins. A replay will be available on the company's website following the event.
Details
News Market Reaction – CARL
On Aug 14, the day this news came out, CARL closed 1.23% above the previous close.
Data tracked by StockTitan Argus for the Aug 14 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after market close on Thursday, August 28, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.
Conference Call Information
To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call.
Event Date: Thursday, August 28, 2025
Time: 1:30 PM Pacific Time
Participant Registration: https://register-conf.media-server.com/register/BI48d0cdca88dd4be5ad645de9962d27c3
A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website here.
About Carlsmed
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
IR@Carlsmed.com
Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.